Published in Medical Letter on the CDC and FDA, May 16th, 2004
This second patent covers key aspects of the ADBF technology as well as innovations and enhancements to the Quantix family of products for the measurement of blood flow in a variety of clinical applications that are also protected by U.S. patent #6,503,205.
Additional patents covering the Cardiosonix technology are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.